For manufacturers who want more than just to ship products into Turkiye
ER Medical works with manufacturers that are serious about entering Turkiye by bringing clinical access, pharmacy reach, and regulatory management together under one coordinated structure.
01
Manufacturer-first model
Designed around long-term brand building rather than short-term resale activity.
02
Single point of coordination
Clinical, regulatory, and commercial workstreams are managed together rather than in isolation.
03
Structured entry from day one
The process moves in a planned sequence from market assessment through field activation.
This model is not for every brand, but it is built for the right one
ER Medical works with manufacturers that want to enter Turkiye in a structural and lasting way, not simply as a short-term trial.
Medical device and supplement manufacturers
UK- or Ireland-based brands with CE-certified products or products that may fall within TITCK scope.
Those who see Turkiye as a priority market
Manufacturers looking for sustainable presence in clinical and pharmacy channels rather than a one-off export transaction.
Those who take regulation seriously
Brands that want to establish TITCK compliance correctly from the outset and avoid issues later in the process.
Not the right fit for this model
Bulk export models driven only by price advantage
Brands planning short-term trial sales only
Approaches that ignore regulatory compliance
Four steps from partnership application to market activation
Each step is sequenced to support the next. Rather than an unprepared entry, the process is designed for a planned and coordinated launch.
Assess product and market fit
We analyse category, regulatory route, and channel potential together to build a realistic entry strategy for Turkiye.
Build the entry plan together
Regulatory, clinical, and commercial workstreams are aligned before launch. It becomes clear which channel should activate and when.
Open channels in a coordinated way
Physician networks, clinics, distributors, and the pharmacy platform are activated not all at once, but in the right order and with coordination.
Grow in a measured and sustainable way
Performance is tracked and optimised through a partnership model designed for long-term market presence.
Not disconnected services, but an integrated entry model
When manufacturers work with ER Medical, they gain a single point of coordination. Regulatory, clinical, and commercial processes are not followed separately; they move together.
Regulatory route analysis and launch planning
TITCK requirements, licensing, and import processes are managed end-to-end.
Clinical and medical network access
Physician and clinic relationships are activated to introduce the product in the right clinical context.
Pharmacy platform access
Product visibility and listing support on the national ordering platform reaching 24,000-30,000 pharmacies.
Sales route and distributor coordination
Commercial route design and field execution support across specialist and distribution channels.
Let us assess your route into Turkiye together
Share your product category, current situation, and objectives. Let us review together how you should enter Turkiye and which steps should come first.